Breathing problems after Trilostane (Vetoryl) in dogs
The FDA has received 771 reports of breathing problems in dogs after Trilostane. That is 6.5% of all reports for this medicine, compared with 2.7% across reports for all dog medicines, so it is reported unusually often with this medicine.
771Reports
60%Marked serious
13%Recovered
19%Died or euthanised
51 daysTypical onset
Sponsored
How soon it started
How the animals did
Problems reported at the same time
Age of the animals
About this medicine
Trilostane treats Cushing's disease (an overactive adrenal gland).
Products with this ingredient include Vetoryl. The FDA hides brand names in its public data, so these reports cover every product with the same active ingredients.
Questions owners ask
- Can Trilostane cause breathing problems in dogs?
- 771 reports link the two, but a report alone does not prove the medicine was the cause: other illnesses, other medicines or coincidence can be involved. Your vet can judge it for your animal.
- How soon after a dose was it reported?
- In half of the reports with dates, it started within 51 days of the first dose.
- What should I do?
- Don't give another dose until you've spoken to your vet, and keep the packaging so you can tell them the product and dose. Your vet can also report it to the FDA (or you can, through the manufacturer or FDA form 1932a).
Breathing problems with similar medicines
- Breathing problems after Insulin 193 reports · 2.6% of its reports
- Breathing problems after Phenylpropanolamine (Proin) 500 reports · 12% of its reports
- Breathing problems after Levothyroxine 248 reports · 8.2% of its reports
All reported side effects of Trilostane in dogs · Medicines most reported with breathing problems